قالب وردپرس درنا توس
Home / Business / Pfizer Joins Pharmaceutical Stocks with Humira Biosimilar Deal by AbbVie | Business of the investor daily

Pfizer Joins Pharmaceutical Stocks with Humira Biosimilar Deal by AbbVie | Business of the investor daily



Dow Jones component Pfizer (PFE) joined licensing agreements with a number of pharmaceuticals on Friday to launch the biosimilars of AbbVie (megablocker drug) Humira. 19659002] X



In today's afternoon trading on the stock market, the AbbVie share rose 2.4%, close to 92.10. The Pfizer share rose by a fraction near 45.80. The shares traded briefly above a purchase point at 45.91 from a flat base, but the volume remained low. Meanwhile, pharmaceuticals rose by a fraction overall.

Humira is the main drug of AbbVie. It treats various forms of arthritis, psoriasis and Crohn's disease. In 201

7, Humira's revenue was $ 18.4 billion, about two-thirds of AbbVie's total revenue. The deal will enable Pfizer to launch its Humira biosimilar in Europe as soon as it receives approval.

"This agreement will facilitate patient access to the (Humira) biosimilar product proposed by Pfizer, which we expect will be an important adjunct to our broad portfolio of biosimilar drugs," said Richard Blackburn, Pfizer's global president Inflammation and Immunology, in a written statement.

Pfizer biosimilar will be late in the US market

Pfizer may launch its Humira biosimilar in November 2023 in the US. [1] With this, Pfizer lies behind Amgen (AMGN), which can launch in January 2023, and Mylan (MYL), which can launch in July 2023. Among other offerings, Biogen (BIIB) and Novartis (NVS) may launch in June or September of the same year.

Friday's deal resolves all ongoing litigation between Pfizer and AbbVie over a Humira biosimilar.

Several pharmaceutical stocks You have Humira Biosimilars in Europe. Amgen, Biogen and Novartis launched their imitators in October. Biosimilars are nearly identical copies of biological drugs.

YOU WANT:

Earnings Calendar, Analyst Estimates, and Watchable Stocks

Best Growth Stocks to Buy and Watch: See IBD Stock List Updates

IBD Bearings of the Day


Source link